Quality, Compliance, Technology & Outcomes Committee

Statement of Purpose

The Quality, Compliance, Technology & Outcomes Committee (the "QCTO Committee" or the "Committee") is chartered by the Board of Directors to provide assistance to the Board in executing its responsibilities concerning:

1. The quality of the Company's products and services, the health care, regulatory, legal, and professional standards pursued by the Company and the environment necessary to ensure for the delivery of excellent clinical care, products and services.

2. The adequacy and relevancy of the Company's information technology systems and processes, scientific and technical strategy and the allocation of the Company's resources to those technological efforts that offer the greatest potential growth to the Company within the framework of the strategic objectives.

 3. The oversight and evaluation of the company's compliance program, including providing input and guidance into the annual goals and performance review of the Chief Compliance Officer (CCO).

4. The development of the Company's strategic initiatives in patient outcomes and satisfaction, including their associated performance metrics.

Composition and Meetings

The QCTO Committee shall consist of at least two directors appointed by, and who serve at the request of the Board. The Board shall designate one of the members of the Committee as its Chair. The Committee shall meet at least quarterly, or more frequently as circumstances may dictate. The Committee shall work with the Audit Committee as needed to review the Compliance Program. The Committee Chair will approve an agenda in advance of each meeting. 

​Responsibilities and Duties   

The QCTO Committee shall oversee the Company's quality, compliance, technology and outcomes strategic initiatives and/or monitor and evaluate the overall effectiveness of the programs as outlined below: 

  1. Oversee the Company's overall programs inclusive of quality committees, compliance and information/technology initiatives impacting clinical care, products and services. Activities include reviewing, periodic monitoring and approval of each program's: (a) organization, implementation and effectiveness; (b) defined initiatives, indicators, and risk management.            

  2. Support the CCO in the development and implementation of Compliance programs across all Hanger businesses.  Direct governance and leadership in all regulatory and clinical compliance matters within Hanger, Inc. except those financial reporting items specifically identified as the responsibility of the Audit Committee. Coordinate with the Audit Committee to ensure coverage of all areas. Direct CCO and CISO (Chief Information Security Officer) to coordinate monitoring of compliance with HIPAA rules and increased cyber security threats.

  3. Support and review the development of clinical guidelines and outcomes measures.           

  4. Evaluate effectiveness of the Company's scientific and technological efforts and investments in developing new clinical services, products and businesses.

  5. Ensure proper communication of significant QCTO issues to the full Board of Directors.

  6. Review and reassess the adequacy of this Charter at least annually. Submit changes to the Charter to the Board for approval.

The QCTO Committee has the authority to conduct any investigation appropriate to fulfill its responsibilities, and it has direct access to anyone in the Company, as well as, any third party who may perform consulting services for the Company related to the scope of the Committee's responsibilities. The QCTO Committee has the ability to retain, at the Company's expense, legal, accounting or other experts it deems necessary in the performance of its duties. 

As adopted on February 7, 2017